TGFB1 and neoplasm: Therefore, secretion of TGF-β in tumor microenvironment can sculpt the immune environment by modulating the inhibitory ligands on tumor cells as well as the inhibitory receptors on NK cells, and these changes could be predictive of a negative prognosis in cancer patients.